Depression News and Research

Latest Depression News and Research

New research may help adopt acupuncture as a treatment option for NHS patients

Important new research about the effects of acupuncture on the brain may provide an understanding of the complex mechanisms of acupuncture and could lead to a wider acceptability of the treatment.

4 Feb 2010

Older married female cancer survivors have added health problems

A recently published study from Case Western Reserve University's Mandel School of Applied Social Sciences found 245 older married women who survived cancer had more health problems as compared to a sample of 245 married women without cancer.

4 Feb 2010

Neuroscience research and clinical care launched at UT Medical School

Innovative neuroscience research and expanded clinical care have been launched at the new Center of Excellence on Mood Disorders at The University of Texas Medical School at Houston.

4 Feb 2010

Regular physical activity prevents chronic illness: Surgeon General urged to make outdoor time a health priority

National Wildlife Federation (NWF), more than 200 health, conservation, youth, and other organizations, and 16,300 Americans are urging the new surgeon general to make time outdoors a health priority for children.

4 Feb 2010

Acupuncture viable for treatment of depression during pregnancy

In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting -, in Chicago, researchers will unveil findings that show that acupuncture may be an effective treatment for depression during pregnancy.

4 Feb 2010

Study shows Cymbalta reduces chronic low back pain

In a new study, 60 mg of Cymbalta® (duloxetine HCl) taken once daily significantly reduced chronic low back pain, as measured by the Brief Pain Inventory (BPI) average pain rating, compared with placebo.

3 Feb 2010

FDA approves Labopharm's OLEPTRO antidepressant for MDD

Labopharm Inc. today announced the U.S. Food and Drug Administration (FDA) has approved OLEPTRO(TM) (trazodone hydrochloride) Extended Release Tablets, a novel once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults. OLEPTRO(TM) utilizes CONTRAMID(R), Labopharm's clinically validated technology that controls the release of active substances within oral medications.

3 Feb 2010

Older male Italian immigrants more prone to depression

Older male Italian immigrants are almost twice as likely to suffer from depression as their Australian-born counterparts, researchers from the University of Sydney's School of Public Health have found.

3 Feb 2010

Study indicates majority of physicians are not following DSM-IV guidelines for major depressive disorder

A new study led by Mark Zimmerman, MD, of Rhode Island Hospital indicates that a majority of non-psychiatrist physicians and a substantial minority of psychiatrists reported that they often do not use the criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) when diagnosing major depressive disorder (MDD) in patients. The study appears online ahead of print in the Journal of Clinical Psychiatry.

3 Feb 2010

CPS supports NACI recommendations for new shingles vaccine

The Canadian Pain Society (CPS) supports the National Advisory Committee on Immunization (NACI) recommendations for the use of a vaccine to significantly reduce the risk of developing herpes zoster (shingles) and post herpetic neuralgia in adults over the age of 60 without contraindications.

3 Feb 2010

One-third of doctors and diabetes patients prioritize health conditions differently

About one-third of doctors and their patients with diabetes do not see eye to eye on the most important health conditions to manage, according to a survey by the University of Michigan Medical School.

3 Feb 2010

Women's metabolic disorder remains largely undiagnosed

Gail Donnelly's classmates nicknamed her "Knobby" because she was so skinny all her bones seemed to poke out from under her skin. But when Donnelly turned 27, that once knobby frame disappeared under mysteriously ballooning weight.

2 Feb 2010

Javelin Pharmaceuticals' NDA for Dyloject Injection accepted for formal review

Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that its New Drug Application (NDA) submitted on December 2, 2009 to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, has been accepted for formal review.

2 Feb 2010

Persons with impaired hearing should be encouraged by family members to seek appropriate treatment

Recent data arising out of the Better Hearing Institute's "MarkeTrak" national study demonstrates that hearing loss is prevalent, serious, and often denied by the sufferer. The information revealed suggests that family members of the hearing impaired should actively encourage their loved ones to address their hearing problem, an effort which will greatly benefit both the hard of hearing and their kin.

2 Feb 2010

Extended nicotine patch therapy benefits relapsing smokers trying to quit

New research from the University of Pennsylvania School of Medicine may help more smokers keep their New Year's resolution by helping them quit smoking. Extended use of a nicotine patch - 24 weeks versus the standard eight weeks recommended by manufacturers - boosts the number of smokers who maintain their cigarette abstinence and helps more of those who backslide into the habit while wearing the patch, according to a study which will be published in the February 2 issue of Annals of Internal Medicine.

2 Feb 2010

Caregivers of ICU survivors endure more stress than those caring for Alzheimer's disease patients

Intensive care unit patients are not the only ones likely to be severely depressed in the aftermath of hospitalization. Family and friends who care for them often suffer emotional and social hardship, too, according to a prospective study from the University of Pittsburgh School of Medicine that is the first to monitor patients and caregivers during a one-year period for predictors of depression and lifestyle disruption.

2 Feb 2010

Genetic mutations may trigger suicidal behavior in depressed patients

Single mutations in genes involved with nerve cell formation and growth appear to be associated with the risk of attempting suicide among individuals with depression, according to a report posted online today that will appear in the April print issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

2 Feb 2010

Evidence suggests antidepressants may improve post-stroke recovery

Patients who received the antidepressant escitalopram following a stroke appeared to recover more of their thinking, learning and memory skills than those taking placebo or participating in problem-solving therapy, according to a report in the February issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

2 Feb 2010

Survey finds Americans hesitant to seek mental health for confidentiality reasons

A survey from the American Psychiatric Association has found that workers' fears about losing their status at work and about confidentiality are the reasons American workers hesitate to seek treatment for mental health issues, HealthDay/BusinessWeek reports.

1 Feb 2010

New mental health coverage rules promise to end some discrimination

Reuters: Employer-provided group health plans must offer the same level of coverage for mental illness and drug abuse treatment as for other ailments, according to federal regulations issued on Friday.

31 Jan 2010